Purpose Male breast cancer (BC) is rare, representing approximately 1% of cancers that
occur in men and approximately 1% of all BCs worldwide. Because male BC is rare, not …

Background The causes, optimal treatments, and medical/psychosocial sequelae of breast
cancer in men are poorly understood. Design A systematic review of the English language …

Male breast cancer (MBC) is a rare disease, accounting for less than 1% of all breast cancer
diagnoses worldwide. Although breast carcinomas share certain characteristics in both …

Global international trends in female breast cancer incidence have been described
previously but no comparable analysis of male breast cancer incidence rates has been …

BACKGROUND: Infiltrating MBC represents less than 1% of all male cancers. Our study
details clinico-pathological features, treatments and prognostic factors in a large French …

Male breast cancer is rare, accounting for 1% of all breast cancer diagnoses in the USA.
Because of its rarity, most major breast cancer trials have included only female patients. This …

Papillary carcinoma of the breast represents~ 0.5% of all newly diagnosed cases of breast
cancer. The prevalence of both invasive and in situ papillary carcinoma seems to be greater …

Aim Several prognostic histological features have been established in female breast cancer
(BC), but it is unknown whether these can be extrapolated to male BC patients. The aim of …

Male breast cancer remains understudied despite evidence of rising incidence. Using a co-
ordinated multi-centre approach, we present the first large scale biomarker study to define …

Male breast disease includes a variety of benign and malignant conditions, many of which
are hormonally influenced. Gynecomastia and skin lesions account for the majority of …